0.63 USD
▼-0.07-10.29%
盘后 0.63 -0.02%
2026-11-20
市值
$4.78M
市盈率
—
EPS
-4.49
股息率
—
52 周区间
0.43 – 18.89
成交量
256.43K
Beta
1.47
目标价
21.00
52W 低 0.4352W 高 18.89
价格走势
公司简介
Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company’s lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary li...